On Invalid Date, Eterna Therapeutics (NASDAQ: ERNA) reported Q4 2023 earnings per share (EPS) of -$1.14, up 11.76% year over year. Total Eterna Therapeutics earnings for the quarter were -$6.16 million. In the same quarter last year, Eterna Therapeutics's earnings per share (EPS) was -$1.02.
As of Q2 2024, Eterna Therapeutics's earnings has grown year over year. Eterna Therapeutics's earnings in the past year totalled -$21.68 million.
What is ERNA's earnings date?
Eterna Therapeutics's earnings date is Invalid Date. Add ERNA to your watchlist to be reminded of ERNA's next earnings announcement.
What was ERNA's revenue last quarter?
On Invalid Date, Eterna Therapeutics (NASDAQ: ERNA) reported Q4 2023 revenue of $17.00 thousand up Infinity% year over year. In the same quarter last year, Eterna Therapeutics's revenue was $0.00.
What was ERNA's revenue growth in the past year?
As of Q2 2024, Eterna Therapeutics's revenue has grown null year over year. Eterna Therapeutics's revenue in the past year totalled $68.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.